Replimune Group, Inc. (REPL)
7.715
-0.18
(-2.34%)
USD |
NASDAQ |
Jan 23, 16:00
7.715
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Total Assets (Annual): 551.33M for March 31, 2025
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Rapt Therapeutics, Inc. | 240.32M |
| Olema Pharmaceuticals, Inc. | 556.07M |
| CorMedix, Inc. | 118.85M |
| Verastem, Inc. | 101.54M |
| Anavex Life Sciences Corp. | 103.82M |